Gene · 574456
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy. | Heliyon | 2024 | 39100497 | PubTator, text mining | PubMed |
| Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells. | Toxicol Lett | 2024 | 38971455 | PubTator, text mining | PubMed |
| LncRNA TRPM2-AS promotes endometrial carcinoma progression and angiogenesis via targeting miR-497-5p/SPP1 axis. | Cell Mol Biol Lett | 2024 | 38956502 | PubTator, text mining | PubMed |
| microRNA and the Post-Transcriptional Response to Oxidative Stress during Neuronal Differentiation: Implications for Neurodevelopmental and Psychiatric Disorders. | Life (Basel) | 2024 | 38792584 | PubTator, text mining | PubMed |
| miR-497 Target Gene Regulatory Network in Angiosarcoma. | Mol Cancer Res | 2024 | 38771248 | PubTator, text mining | PubMed |
| A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma. | Can J Gastroenterol Hepatol | 2024 | 38529202 | PubTator, text mining | PubMed |
| Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer. | Pathol Res Pract | 2024 | 38452582 | PubTator, text mining | PubMed |
| Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer. | J Cancer Res Clin Oncol | 2024 | 38285101 | PubTator, text mining | PubMed |
| Clinical importance of serum miRNA levels in breast cancer patients. | Discov Oncol | 2024 | 38280134 | PubTator, text mining | PubMed |
| Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review. | Medicine (Baltimore) | 2024 | 38277554 | PubTator, text mining | PubMed |
| Retracted: Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer. | Biomed Res Int | 2024 | 38230108 | PubTator, text mining | PubMed |
| In-silico and in-vitro evidence suggest LINC01405 as a sponge for miR-29b and miR-497-5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma. | Cancer Rep (Hoboken) | 2024 | 38225865 | PubTator, text mining | PubMed |
| miR-497/195 Cluster Affects the Development of Colorectal Cancer by Targeting FRA1. | Mol Biotechnol | 2024 | 38147235 | PubTator, text mining | PubMed |
| A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. | Obstet Gynecol Sci | 2024 | 38050353 | PubTator, text mining | PubMed |
| miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. | Noncoding RNA Res | 2024 | 38035044 | PubTator, text mining | PubMed |
| Circular RNA in cervical cancer: Fundamental mechanism and clinical potential. | Noncoding RNA Res | 2024 | 38035041 | PubTator, text mining | PubMed |
| Dynamic expression analysis of peripheral blood derived small extracellular vesicle miRNAs in sepsis progression. | J Cell Mol Med | 2024 | 38014923 | PubTator, text mining | PubMed |
| MiR-488-3p facilitates wound healing through CYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2. | J Diabetes Investig | 2024 | 37961023 | PubTator, text mining | PubMed |
| LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers. | Adv Sci (Weinh) | 2024 | 37939296 | PubTator, text mining | PubMed |
| Long non-coding RNA FGD5 antisense RNA 1 targets Baculovirus inhibitor 5 via microRNA-497-5p to alleviate calcific aortic valve disease. | Clin Hemorheol Microcirc | 2024 | 37355887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574456/papers?page=4